Jeremy Hing - Concepedia

Author

Jeremy Hing

Newcastle University

Also Known As

J Hing, J P Hing, J. Hing, Jeremy Hing, Jeremy P. Hing, Jeremy P. Hing

Publications

969

Citations

H-Index

Concepts

All Affiliations

Newcastle University Johnson & Johnson (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)University of California, San Francisco

About

Jeremy Hing is an author at Newcastle University specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	254
2	Pharmacology	3	3	63
3	Diabetes	1	1	10
4	Epidemiology	1	1	24
5	Perioperative Medicine	1	1	191

Jeremy Hing

Publications

911

Citations

H-Index

Page 1

	Year	Citations
Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors Ian E. Krop, Tim Demuth, Tina Guthrie, Journal of Clinical Oncology	2012	314
Peri-operative risk factors for acute lung injury after elective oesophagectomy S. Tandon, Anna Batchelor, R. Bullock, British Journal of Anaesthesia Acute Lung InjuryMedicinePatient SafetyThoracic SurgerySurgery	2001	191
Temperature-dependent Pharmacokinetics and Pharmacodynamics of Vecuronium James E. Caldwell, Tom Heier, Peter M. C. Wright, Anesthesiology	2000	129
Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups Jianguo Li, Mark Lovern, Michelle Green, Clinical and Translational Science	2018	99
Analysis of Toxicokinetic Data Using NONMEM: Impact of Quantification Limit and Replacement Strategies for Censored Data Jeremy Hing, Steven G. Woolfrey, Dennis Greenslade, Journal of Pharmacokinetics and Pharmacodynamics	2001	50
Pharmacodynamic Analysis of Recombinant Human Erythropoietin Effect on Reticulocyte Production Rate and Age Distribution in Healthy Subjects Juan José Pérez Ruixo, Wojciech Krzyżański, Jeremy Hing Clinical Pharmacokinetics InflammationHealthy SubjectsPharmacologyHematologyBlood Cell	2008	43
Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults Seth C. Hopkins, Soujanya Sunkaraneni, Estela Skende, Clinical Drug Investigation	2015	30
Is Mixed Effects Modeling or Naïve Pooled Data Analysis Preferred for the Interpretation of Single Sample per Subject Toxicokinetic Data? Jeremy Hing, Steven G. Woolfrey, Dennis Greenslade, Journal of Pharmacokinetics and Pharmacodynamics Mixed EffectsPsychiatrySingle SampleSubject Toxicokinetic DataStatistics	2001	24
Pharmacokinetic simulation for switching from galantamine immediate-release to extended-release formulation Jeremy Hing, Vladimir Piotrovsky, Hui C. Kimko, Current Medical Research and Opinion	2005	11
Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics Kienna Mills, Peter M. C. Wright, B. J. Pollard, British Journal of Anaesthesia Pharmacological StudyMedicineExperimental PharmacologyPharmacotherapyPharmacology	1999	10

Page 1